L
Lars Jacobsson
Researcher at Lund University
Publications - 310
Citations - 8703
Lars Jacobsson is an academic researcher from Lund University. The author has contributed to research in topics: Population & Radioimmunotherapy. The author has an hindex of 46, co-authored 306 publications receiving 8118 citations. Previous affiliations of Lars Jacobsson include SP Technical Research Institute of Sweden & University of Gothenburg.
Papers
More filters
Journal ArticleDOI
Development of a new inventory for assessing memories of parental rearing behaviour.
TL;DR: A new inventory to assess the own memories of parental rearing behaviour was constructed and the subscales cover such rearing practices as for example overinvolvement, affection, overprotectiveness, guilt engendering, rejection.
Journal ArticleDOI
The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction.
Evald Rosengren,Richard Bucala,Pierre Åman,Lars Jacobsson,Gerd Odh,Christine N. Metz,Hans Rorsman +6 more
TL;DR: Although the tested substrate, D-dopachrome, does not occur naturally, the observation that MIF has tautomerase activity suggests that Mif may mediate its biological effects by an enzymatic reaction.
Journal ArticleDOI
Perception of stigma among family members of individuals with schizophrenia and major affective disorders in rural Ethiopia.
Teshome Shibre,Alemayehu Negash,Gunnar Kullgren,Derege Kebede,Atalay Alem,Abebaw Fekadu,Daniel Fekadu,G Madhin,Lars Jacobsson +8 more
TL;DR: Stigma was found to be a common problem, with few differences between socio-demographic groups or between types of mental disorder, with common beliefs about causes differ from those held by professionals.
Journal ArticleDOI
The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase
Evald Rosengren,Pierre Åman,Sofia Thelin,Christer Hansson,Stefan Ahlfors,Peter Björk,Lars Jacobsson,Hans Rorsman +7 more
TL;DR: The definition of MIF as an enzyme may yield insight into the mechanism of action of this proinflammatory and immunomodulating cytokine.
Journal ArticleDOI
Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab′)2—A Phase I Study
Håkan Andersson,Elin Cederkrantz,Tom Bäck,Chaitanya R. Divgi,Jörgen Elgqvist,Jakob Himmelman,György Horvath,Lars Jacobsson,Holger Jensen,Sture Lindegren,Stig Palm,Ragnar Hultborn +11 more
TL;DR: By intraperitoneal administration of 211At-MX35 F(ab′)2 it is possible to achieve therapeutic absorbed doses in microscopic tumor clusters without significant toxicity, as indicated by pharmacokinetics and dosimetric results.